|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,450,000 |
Market
Cap: |
1.29(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$26.1 - $47.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 623 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
119,323 |
119,323 |
201,796 |
301,022 |
Total Sell Value |
$3,656,226 |
$3,656,226 |
$6,836,738 |
$12,842,588 |
Total People Sold |
1 |
1 |
15 |
17 |
Total Sell Transactions |
3 |
3 |
36 |
60 |
End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wicki Andreas |
Director |
|
2014-06-09 |
4 |
AS |
$84.55 |
$5,809,185 |
I/I |
(68,000) |
1,327,407 |
|
- |
|
Wicki Andreas |
Director |
|
2014-06-06 |
4 |
AS |
$82.71 |
$3,324,753 |
I/I |
(40,200) |
1,395,407 |
|
- |
|
Wicki Andreas |
Director |
|
2014-06-05 |
4 |
AS |
$82.53 |
$1,914,668 |
I/I |
(23,200) |
1,435,607 |
|
- |
|
Wicki Andreas |
Director |
|
2014-06-04 |
4 |
AS |
$82.40 |
$370,809 |
I/I |
(4,500) |
1,458,807 |
|
- |
|
Wicki Andreas |
Director |
|
2014-06-03 |
4 |
AS |
$80.72 |
$4,633,207 |
I/I |
(57,400) |
1,463,307 |
|
- |
|
Wicki Andreas |
Director |
|
2014-06-02 |
4 |
AS |
$80.52 |
$853,498 |
I/I |
(10,600) |
1,520,707 |
|
- |
|
Wicki Andreas |
Director |
|
2014-05-27 |
4 |
AS |
$77.93 |
$5,018,750 |
I/I |
(64,400) |
1,531,307 |
|
- |
|
Wicki Andreas |
Director |
|
2014-05-21 |
4 |
AS |
$77.80 |
$280,086 |
I/I |
(3,600) |
1,595,707 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-05-12 |
4 |
AS |
$75.00 |
$750,000 |
D/D |
(10,000) |
0 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-05-12 |
4 |
OE |
$5.49 |
$54,900 |
D/D |
10,000 |
10,000 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-05-09 |
4 |
AS |
$74.08 |
$1,481,600 |
D/D |
(20,000) |
0 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-05-09 |
4 |
OE |
$1.61 |
$58,724 |
D/D |
20,000 |
20,000 |
|
- |
|
Stack David M |
President, CEO and Chairman |
|
2014-05-09 |
4 |
AS |
$73.40 |
$1,848,395 |
D/D |
(25,000) |
1,208 |
|
- |
|
Stack David M |
President, CEO and Chairman |
|
2014-05-09 |
4 |
OE |
$1.61 |
$40,250 |
D/D |
25,000 |
26,208 |
|
- |
|
Brege Laura |
Director |
|
2014-05-09 |
4 |
AS |
$73.57 |
$738,450 |
D/D |
(10,000) |
0 |
|
- |
|
Brege Laura |
Director |
|
2014-05-09 |
4 |
OE |
$10.81 |
$117,610 |
D/D |
10,000 |
10,000 |
|
- |
|
Wicki Andreas |
Director |
|
2014-05-08 |
4 |
AS |
$75.76 |
$1,759,215 |
I/I |
(23,220) |
1,599,307 |
|
- |
|
Scibetta James S |
SVP, Chief Financial Officer |
|
2014-05-08 |
4 |
AS |
$74.27 |
$1,125,681 |
D/D |
(15,000) |
5,000 |
|
- |
|
Scibetta James S |
SVP, Chief Financial Officer |
|
2014-05-08 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,000 |
|
- |
|
Wicki Andreas |
Director |
|
2014-05-07 |
4 |
AS |
$75.64 |
$45,386 |
I/I |
(600) |
1,622,527 |
|
- |
|
Wicki Andreas |
Director |
|
2014-05-06 |
4 |
AS |
$75.78 |
$3,348,062 |
I/I |
(44,180) |
1,623,127 |
|
- |
|
Longenecker John P Phd |
Director |
|
2014-03-28 |
4 |
AS |
$64.63 |
$64,630 |
D/D |
(1,000) |
0 |
|
- |
|
Longenecker John P Phd |
Director |
|
2014-03-28 |
4 |
OE |
$29.90 |
$29,900 |
D/D |
1,000 |
1,000 |
|
- |
|
Stack David M |
President, CEO and Chairman |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
221 |
1,208 |
|
- |
|
Patou Gary |
Chief Medical Officer |
|
2014-03-11 |
4 |
A |
$0.00 |
$0 |
I/I |
504 |
702 |
|
- |
|
253 Records found
|
|
Page 2 of 11 |
|
|